Q3 2013 report roundup -- Gevo, Amyris, and Solazyme disclose financials and make announcements

Gevo ended the quarter with $25.7 million in cash and cash equivalents, with a net cash consumption of $14.9 million since June 30, 2013. On the revenue side, $1.1 million came in, which included $0.4 million from selling bio-based jet fuel to the U.S. Air Force, revenue under Gevo's agreement wi...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Amyris partners with Ingredion to bring its Reb M sweetener to B2B market

News Commentary | May 13, 2021

With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription

Microphyt to build new microalgae biorefinery following €15 million grant

News Commentary | July 08, 2021

The Bio‑Based Industries Joint Undertaking (BBI JU) has granted €15 million in funding to French company Microphyt (Lux Take: Engage) through the SCALE project. This four‑year project, spearheaded by Microphyt, will bring together 11 industrial partners and enable the construction of a microalgae ... Not part of subscription

Clariant and India Glycols establish JV for renewable ethylene oxide (EO) derivatives

News Commentary | July 14, 2021

Operating as Clariant IGL Specialty Chemicals, the JV combines India Glycols' renewable bio‑EO derivatives business with Clariant's Industrial & Consumer Specialties business in India, Sri Lanka, Bangladesh, and Nepal. This partnership isn't too surprising given the rise in demand for "eco‑... Not part of subscription